Assembly Biosciences, Inc.

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for William R Ringo. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at William R Ringo har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:SNSE / Sensei Biotherapeutics, Inc. Director 23.399
US:ASMB / Assembly Biosciences, Inc. Director 20.000
Director 0
US:DERM / Journey Medical Corporation Director 0
US:IMDZ / Immune Design Corp. Director 0
US:SGMO / Sangamo Therapeutics, Inc. Director 0
US:MRTX / Mirati Therapeutics, Inc. Director 10.000
US:ONXX / Onyx Pharmaceuticals Inc Director 0
US:PFE / Pfizer Inc. Senior Vice President 5.000
US:LJPC / La Jolla Pharmaceutical Co. Director 10.000
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af William R Ringo. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb ASMB / Assembly Biosciences, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ASMB / Assembly Biosciences, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

ASMB / Assembly Biosciences, Inc. Insider Trades
Insidersalg ASMB / Assembly Biosciences, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ASMB / Assembly Biosciences, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2017-05-12 ASMB RINGO WILLIAM R 3.461 22,0000 288 264,0000 76.142 46 20.3500 -70.281 -92,30

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

ASMB / Assembly Biosciences, Inc. Insider Trades
Insiderkøb DERM / Journey Medical Corporation – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ASMB / Assembly Biosciences, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

DERM / Journey Medical Corporation Insider Trades
Insidersalg DERM / Journey Medical Corporation – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ASMB / Assembly Biosciences, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

DERM / Journey Medical Corporation Insider Trades
Insiderkøb SGMO / Sangamo Therapeutics, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ASMB / Assembly Biosciences, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

SGMO / Sangamo Therapeutics, Inc. Insider Trades
Insidersalg SGMO / Sangamo Therapeutics, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ASMB / Assembly Biosciences, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2017-09-20 SGMO RINGO WILLIAM R 31.000 14,3741 31.000 14,3741 445.597 42 11.6 -85.997 -19,30
2015-01-05 SGMO RINGO WILLIAM R 2.200 15,1954 2.200 15,1954 33.430
2014-02-14 SGMO RINGO WILLIAM R 25.000 18,0630 25.000 18,0630 451.575

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

SGMO / Sangamo Therapeutics, Inc. Insider Trades
Insiderkøb SNSE / Sensei Biotherapeutics, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ASMB / Assembly Biosciences, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

SNSE / Sensei Biotherapeutics, Inc. Insider Trades
Insidersalg SNSE / Sensei Biotherapeutics, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ASMB / Assembly Biosciences, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

SNSE / Sensei Biotherapeutics, Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af William R Ringo som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2023-07-12 2023-07-10 4 SNSE Sensei Biotherapeutics, Inc.
Common Stock
A - Award 4.466 23.399 23,59
2022-05-27 2022-05-25 4 ASMB ASSEMBLY BIOSCIENCES, INC.
Stock Option (right to buy)
A - Award 20.000 20.000
2022-03-09 2022-03-08 4 SNSE Sensei Biotherapeutics, Inc.
Stock Option (Right to Buy)
A - Award 29.100 29.100
2022-03-09 2022-03-08 4 SNSE Sensei Biotherapeutics, Inc.
Common Stock
A - Award 10.000 18.933 111,94
2022-03-09 2022-03-08 4 SNSE Sensei Biotherapeutics, Inc.
Common Stock
A - Award 8.933 8.933
2021-05-24 2021-05-20 4 ASMB ASSEMBLY BIOSCIENCES, INC.
Stock Option (right to buy)
A - Award 15.000 15.000
2021-04-19 2021-04-16 4 FPRX FIVE PRIME THERAPEUTICS, INC.
Employee Stock Option (right to buy)
D - Sale to Issuer -27.769 0 -100,00
2021-04-19 2021-04-16 4 FPRX FIVE PRIME THERAPEUTICS, INC.
Employee Stock Option (right to buy)
D - Sale to Issuer -52.408 0 -100,00
2021-04-19 2021-04-16 4 FPRX FIVE PRIME THERAPEUTICS, INC.
Employee Stock Option (right to buy)
D - Sale to Issuer -37.998 0 -100,00
2021-04-19 2021-04-16 4 FPRX FIVE PRIME THERAPEUTICS, INC.
Employee Stock Option (right to buy)
D - Sale to Issuer -40.868 0 -100,00
2021-04-19 2021-04-16 4 FPRX FIVE PRIME THERAPEUTICS, INC.
Employee Stock Option (right to buy)
D - Sale to Issuer -49.552 0 -100,00
2021-04-19 2021-04-16 4 FPRX FIVE PRIME THERAPEUTICS, INC.
Employee Stock Option (right to buy)
D - Sale to Issuer -50.367 0 -100,00
2021-04-19 2021-04-16 4 FPRX FIVE PRIME THERAPEUTICS, INC.
Employee Stock Option (right to buy)
D - Sale to Issuer -46.939 0 -100,00
2021-04-19 2021-04-16 4 FPRX FIVE PRIME THERAPEUTICS, INC.
Employee Stock Option (right to buy)
D - Sale to Issuer -34.451 0 -100,00
2021-04-19 2021-04-16 4 FPRX FIVE PRIME THERAPEUTICS, INC.
Stock Option (right to buy)
D - Sale to Issuer -15.000 0 -100,00
2021-04-19 2021-04-16 4 FPRX FIVE PRIME THERAPEUTICS, INC.
Stock Option (right to buy)
D - Sale to Issuer -10.000 0 -100,00
2021-04-19 2021-04-16 4 FPRX FIVE PRIME THERAPEUTICS, INC.
Stock Option (right to buy)
D - Sale to Issuer -10.000 0 -100,00
2021-04-19 2021-04-16 4 FPRX FIVE PRIME THERAPEUTICS, INC.
Stock Option (right to buy)
D - Sale to Issuer -12.500 0 -100,00
2021-04-19 2021-04-16 4 FPRX FIVE PRIME THERAPEUTICS, INC.
Stock Option (right to buy)
D - Sale to Issuer -16.600 0 -100,00
2021-04-19 2021-04-05 4 FPRX FIVE PRIME THERAPEUTICS, INC.
Common Stock
G - Gift -10.000 0 -100,00
2020-11-13 2020-11-11 4 FPRX FIVE PRIME THERAPEUTICS, INC.
Employee Stock Option (right to buy)
M - Exercise X -26.000 52.408 -33,16
2020-11-13 2020-11-11 4 FPRX FIVE PRIME THERAPEUTICS, INC.
Employee Stock Option (right to buy)
M - Exercise X -52.959 0 -100,00
2020-11-13 2020-11-11 4 FPRX FIVE PRIME THERAPEUTICS, INC.
Common Stock
S - Sale X -26.000 10.000 -72,22 22,50 -585.000 225.000
2020-11-13 2020-11-11 4 FPRX FIVE PRIME THERAPEUTICS, INC.
Common Stock
M - Exercise 26.000 36.000 260,00 2,80 72.800 100.800
2020-11-13 2020-11-11 4 FPRX FIVE PRIME THERAPEUTICS, INC.
Common Stock
S - Sale X -52.959 10.000 -84,12 22,50 -1.191.578 225.000
2020-11-13 2020-11-11 4 FPRX FIVE PRIME THERAPEUTICS, INC.
Common Stock
M - Exercise 52.959 62.959 529,59 2,22 117.569 139.769
2020-06-15 2020-06-11 4 ASMB ASSEMBLY BIOSCIENCES, INC.
Stock Option (right to buy)
A - Award 10.000 10.000
2020-06-15 2020-02-28 4 ASMB ASSEMBLY BIOSCIENCES, INC.
Common Stock
G - Gift -2.000 17.465 -10,27
2020-05-20 2020-05-19 4 FPRX FIVE PRIME THERAPEUTICS, INC.
Employee Stock Option (right to buy)
A - Award 27.769 27.769
2020-04-20 2020-04-19 4 FPRX FIVE PRIME THERAPEUTICS, INC.
Employee Stock Option (right to buy)
A - Award 78.408 78.408
2020-03-20 2020-03-19 4 FPRX FIVE PRIME THERAPEUTICS, INC.
Employee Stock Option (right to buy)
A - Award 52.959 52.959
2020-02-24 2020-02-20 4 DERM Dermira, Inc.
Restricted Stock Unit
D - Sale to Issuer -3.000 0 -100,00
2020-02-24 2020-02-20 4 DERM Dermira, Inc.
Director Stock Option (right to buy)
D - Sale to Issuer -6.000 0 -100,00
2020-02-24 2020-02-20 4 DERM Dermira, Inc.
Director Stock Option (right to buy)
D - Sale to Issuer -6.000 0 -100,00
2020-02-24 2020-02-20 4 DERM Dermira, Inc.
Director Stock Option (right to buy)
D - Sale to Issuer -6.000 0 -100,00
2020-02-24 2020-02-20 4 DERM Dermira, Inc.
Director Stock Option (right to buy)
D - Sale to Issuer -10.344 0 -100,00
2020-02-24 2020-02-20 4 DERM Dermira, Inc.
Director Stock Option (right to buy)
D - Sale to Issuer -8.620 0 -100,00
2020-02-24 2020-02-20 4 DERM Dermira, Inc.
Director Stock Option (right to buy)
D - Sale to Issuer -18.275 0 -100,00
2020-02-24 2020-02-20 4 DERM Dermira, Inc.
Common Stock
D - Sale to Issuer -6.000 0 -100,00 18,75 -112.500
2020-02-20 2020-02-19 4 FPRX FIVE PRIME THERAPEUTICS, INC.
Employee Stock Option (right to buy)
A - Award 37.998 37.998
2020-01-21 2020-01-20 4 FPRX FIVE PRIME THERAPEUTICS, INC.
Employee Stock Option (right to buy)
A - Award 40.868 40.868
2020-01-21 2020-01-20 4 FPRX FIVE PRIME THERAPEUTICS, INC.
Employee Stock Option (right to buy)
A - Award 40.868 40.868
2019-12-20 2019-12-19 4 FPRX FIVE PRIME THERAPEUTICS, INC.
Employee Stock Option (right to buy)
A - Award 49.552 49.552
2019-11-20 2019-11-19 4 FPRX FIVE PRIME THERAPEUTICS, INC.
Employee Stock Option (right to buy)
A - Award 50.367 50.367
2019-10-21 2019-10-19 4 FPRX FIVE PRIME THERAPEUTICS, INC.
Employee Stock Option (right to buy)
A - Award 46.939 46.939
2019-10-08 2019-10-05 4 FPRX FIVE PRIME THERAPEUTICS, INC.
Employee Stock Option (right to buy)
A - Award 34.451 34.451
2019-06-14 2019-06-12 4 DERM Dermira, Inc.
Common Stock
M - Exercise -3.000 0 -100,00
2019-06-14 2019-06-12 4 DERM Dermira, Inc.
Common Stock
M - Exercise 3.000 6.000 100,00
2019-06-12 2019-06-10 4 FPRX FIVE PRIME THERAPEUTICS INC
Stock Option (right to buy)
A - Award 15.000 15.000
2019-06-06 2019-06-04 4 DERM Dermira, Inc.
Restricted Stock Unit
A - Award 3.000 3.000
2019-06-06 2019-06-04 4 DERM Dermira, Inc.
Director Stock Option (right to buy)
A - Award 6.000 6.000
2019-05-17 2019-05-17 4 ASMB ASSEMBLY BIOSCIENCES, INC.
Stock Option (right to buy)
A - Award 10.000 10.000
2019-04-04 2019-04-02 4 IMDZ IMMUNE DESIGN CORP.
Stock Option (Rt to Buy)
D - Sale to Issuer -12.500 0 -100,00
2019-04-04 2019-04-02 4 IMDZ IMMUNE DESIGN CORP.
Stock Option (Rt to Buy)
D - Sale to Issuer -12.500 0 -100,00
2019-04-04 2019-04-02 4 IMDZ IMMUNE DESIGN CORP.
Stock Option (Rt to Buy)
D - Sale to Issuer -10.000 0 -100,00
2019-01-11 2019-01-09 4 FPRX FIVE PRIME THERAPEUTICS INC
Common Stock
A - Award 10.000 10.000
2019-01-07 2019-01-03 4 IMDZ IMMUNE DESIGN CORP.
Stock Option (right to buy)
A - Award 12.500 12.500
2018-07-03 2018-07-02 4 ASMB ASSEMBLY BIOSCIENCES, INC.
Stock Option (right to buy)
M - Exercise -1.000 49.000 -2,00
2018-07-03 2018-07-02 4 ASMB ASSEMBLY BIOSCIENCES, INC.
Common Stock
S - Sale X -1.000 19.465 -4,89 38,50 -38.503 749.461
2018-07-03 2018-07-02 4 ASMB ASSEMBLY BIOSCIENCES, INC.
Common Stock
M - Exercise X 1.000 20.465 5,14 7,20 7.200 147.348
2018-06-14 2018-06-13 4 DERM Dermira, Inc.
Restricted Stock Unit
M - Exercise -3.000 0 -100,00
2018-06-14 2018-06-13 4 DERM Dermira, Inc.
Common Stock
M - Exercise 3.000 3.000
2018-06-14 2018-06-12 4 DERM Dermira, Inc.
Restricted Stock Unit
A - Award 3.000 3.000
2018-06-14 2018-06-12 4 DERM Dermira, Inc.
Director Stock Option (right to buy)
A - Award 6.000 6.000
2018-06-01 2018-06-01 4 ASMB ASSEMBLY BIOSCIENCES, INC.
Stock Option (right to buy)
M - Exercise -1.000 50.000 -1,96
2018-06-01 2018-06-01 4 ASMB ASSEMBLY BIOSCIENCES, INC.
Common Stock
S - Sale X -1.000 19.465 -4,89 42,47 -42.470 826.679
2018-06-01 2018-06-01 4 ASMB ASSEMBLY BIOSCIENCES, INC.
Common Stock
M - Exercise X 1.000 20.465 5,14 7,20 7.200 147.348
2018-06-01 2018-05-30 4 ASMB ASSEMBLY BIOSCIENCES, INC.
Stock Option (right to buy)
A - Award 7.500 7.500
2018-05-14 2018-05-10 4 FPRX FIVE PRIME THERAPEUTICS INC
Stock Option (right to buy)
A - Award 10.000 10.000
2018-05-02 2018-05-01 4 ASMB ASSEMBLY BIOSCIENCES, INC.
Stock Option (right to buy)
M - Exercise -1.000 51.000 -1,92
2018-05-02 2018-05-01 4 ASMB ASSEMBLY BIOSCIENCES, INC.
Common Stock
S - Sale X -1.000 19.465 -4,89 43,06 -43.060 838.163
2018-05-02 2018-05-01 4 ASMB ASSEMBLY BIOSCIENCES, INC.
Common Stock
M - Exercise X 1.000 20.465 5,14 7,20 7.200 147.348
2018-04-02 2018-04-02 4 ASMB ASSEMBLY BIOSCIENCES, INC.
Stock Option (right to buy)
M - Exercise -1.000 52.000 -1,89
2018-04-02 2018-04-02 4 ASMB ASSEMBLY BIOSCIENCES, INC.
Common Stock
S - Sale X -1.000 19.465 -4,89 49,32 -49.320 960.014
2018-04-02 2018-04-02 4 ASMB ASSEMBLY BIOSCIENCES, INC.
Common Stock
M - Exercise X 1.000 20.465 5,14 7,20 7.200 147.348
2018-03-02 2018-03-01 4 ASMB ASSEMBLY BIOSCIENCES, INC.
Stock Option (right to buy)
M - Exercise -1.000 53.000 -1,85
2018-03-02 2018-03-01 4 ASMB ASSEMBLY BIOSCIENCES, INC.
Common Stock
S - Sale X -1.000 19.465 -4,89 56,37 -56.370 1.097.242
2018-03-02 2018-03-01 4 ASMB ASSEMBLY BIOSCIENCES, INC.
Common Stock
M - Exercise X 1.000 20.465 5,14 7,20 7.200 147.348
2018-02-02 2018-02-01 4 ASMB ASSEMBLY BIOSCIENCES, INC.
Stock Option (right to buy)
M - Exercise -1.000 54.000 -1,82
2018-02-02 2018-02-01 4 ASMB ASSEMBLY BIOSCIENCES, INC.
Common Stock
S - Sale X -1.000 19.465 -4,89 46,86 -46.860 912.130
2018-02-02 2018-02-01 4 ASMB ASSEMBLY BIOSCIENCES, INC.
Common Stock
M - Exercise X 1.000 20.465 5,14 7,20 7.200 147.348
2018-01-08 2018-01-04 4 IMDZ Immune Design Corp.
Stock Option (right to buy)
A - Award 12.500 12.500
2018-01-03 2018-01-02 4 ASMB ASSEMBLY BIOSCIENCES, INC.
Stock Option (right to buy)
M - Exercise -1.000 55.000 -1,79
2018-01-03 2018-01-02 4 ASMB ASSEMBLY BIOSCIENCES, INC.
Common Stock
S - Sale X -1.000 19.465 -4,89 45,04 -45.040 876.704
2018-01-03 2018-01-02 4 ASMB ASSEMBLY BIOSCIENCES, INC.
Common Stock
M - Exercise X 1.000 20.465 5,14 7,20 7.200 147.348
2017-12-04 2017-12-01 4 ASMB ASSEMBLY BIOSCIENCES, INC.
Stock Option (right to buy)
M - Exercise -1.000 56.000 -1,75
2017-12-04 2017-12-01 4 ASMB ASSEMBLY BIOSCIENCES, INC.
Common Stock
S - Sale X -1.000 19.465 -4,89 49,37 -49.370 960.987
2017-12-04 2017-12-01 4 ASMB ASSEMBLY BIOSCIENCES, INC.
Common Stock
M - Exercise X 1.000 20.465 5,14 7,20 7.200 147.348
2017-11-03 2017-11-01 4 ASMB ASSEMBLY BIOSCIENCES, INC.
Stock Option (right to buy)
M - Exercise -1.000 57.000 -1,72
2017-11-03 2017-11-01 4 ASMB ASSEMBLY BIOSCIENCES, INC.
Common Stock
S - Sale X -1.000 19.465 -4,89 29,55 -29.550 575.191
2017-11-03 2017-11-01 4 ASMB ASSEMBLY BIOSCIENCES, INC.
Common Stock
M - Exercise X 1.000 20.465 5,14 7,20 7.200 147.348
2017-11-02 2017-11-01 4 FPRX FIVE PRIME THERAPEUTICS INC
Stock Option (right to buy)
M - Exercise -600 16.600 -3,49
2017-11-02 2017-11-01 4 FPRX FIVE PRIME THERAPEUTICS INC
Common Stock
S - Sale X -600 0 -100,00 45,33 -27.198
2017-11-02 2017-11-01 4 FPRX FIVE PRIME THERAPEUTICS INC
Common Stock
M - Exercise 600 600 11,65 6.990 6.990
2017-10-17 2017-10-16 4 ASMB ASSEMBLY BIOSCIENCES, INC.
Stock Option (right to buy)
M - Exercise -1.000 58.000 -1,69
2017-10-17 2017-10-16 4 ASMB ASSEMBLY BIOSCIENCES, INC.
Common Stock
S - Sale X -1.000 19.465 -4,89 33,70 -33.700 655.970
2017-10-17 2017-10-16 4 ASMB ASSEMBLY BIOSCIENCES, INC.
Common Stock
M - Exercise X 1.000 20.465 5,14 7,20 7.200 147.348
2017-10-17 2017-06-23 4 ASMB ASSEMBLY BIOSCIENCES, INC.
Common Stock
G - Gift -1.000 19.465 -4,89
2017-10-03 2017-10-02 4 FPRX FIVE PRIME THERAPEUTICS INC
Stock Option (right to buy)
M - Exercise -600 17.200 -3,37
2017-10-03 2017-10-02 4 FPRX FIVE PRIME THERAPEUTICS INC
Common Stock
S - Sale X -600 0 -100,00 40,78 -24.468
2017-10-03 2017-10-02 4 FPRX FIVE PRIME THERAPEUTICS INC
Common Stock
M - Exercise 600 600 11,65 6.990 6.990
2017-10-03 2017-09-29 4 FPRX FIVE PRIME THERAPEUTICS INC
Stock Option (right to buy)
M - Exercise -1.200 17.800 -6,32
2017-10-03 2017-09-29 4 FPRX FIVE PRIME THERAPEUTICS INC
Common Stock
S - Sale X -1.200 0 -100,00 40,00 -48.000
2017-10-03 2017-09-29 4 FPRX FIVE PRIME THERAPEUTICS INC
Common Stock
M - Exercise 1.200 1.200 11,65 13.980 13.980
2017-10-02 2017-09-28 4 FPRX FIVE PRIME THERAPEUTICS INC
Stock Option (right to buy)
M - Exercise -2.000 19.000 -9,52
2017-10-02 2017-09-28 4 FPRX FIVE PRIME THERAPEUTICS INC
Common Stock
S - Sale X -2.000 0 -100,00 38,00 -76.000
2017-10-02 2017-09-28 4 FPRX FIVE PRIME THERAPEUTICS INC
Common Stock
M - Exercise 2.000 2.000 11,65 23.300 23.300
2017-09-22 2017-09-20 4 SGMO SANGAMO THERAPEUTICS, INC
Stock Option (Right to Buy)
M - Exercise -31.000 0 -100,00
2017-09-22 2017-09-20 4 SGMO SANGAMO THERAPEUTICS, INC
Common Stock
S - Sale -31.000 800 -97,48 14,37 -445.597 11.499
2017-09-22 2017-09-20 4 SGMO SANGAMO THERAPEUTICS, INC
Common Stock
M - Exercise 31.000 31.800 3.875,00 6,05 187.550 192.390
2017-06-15 2017-06-13 4 DERM Dermira, Inc.
Restricted Stock Unit
A - Award 3.000 3.000
2017-06-15 2017-06-13 4 DERM Dermira, Inc.
Director Stock Option (right to buy)
A - Award 6.000 6.000
2017-06-07 2017-06-05 4 SGMO SANGAMO THERAPEUTICS, INC
Stock Option (Right to Buy)
A - Award 10.000 10.000
2017-06-05 2017-06-01 4 ASMB ASSEMBLY BIOSCIENCES, INC.
Stock Option (Right to Buy)
A - Award 7.500 7.500
2017-05-16 2017-05-12 4 ASMB ASSEMBLY BIOSCIENCES, INC.
Common Stock
S - Sale -3.461 0 -100,00 22,00 -76.142
2017-05-12 2017-05-10 4 FPRX FIVE PRIME THERAPEUTICS INC
Stock Option (right to buy)
A - Award 10.000 10.000
2017-05-12 2017-05-10 4 ASMB ASSEMBLY BIOSCIENCES, INC.
Stock Option (Right to Buy)
M - Exercise -5.000 59.000 -7,81
2017-05-12 2017-05-10 4 ASMB ASSEMBLY BIOSCIENCES, INC.
Common Stock
G - Gift 3.461 3.461
2017-05-12 2017-05-10 4 ASMB ASSEMBLY BIOSCIENCES, INC.
Common Stock
G - Gift -3.461 20.465 -14,47
2017-05-12 2017-05-10 4 ASMB ASSEMBLY BIOSCIENCES, INC.
Common Stock
F - Taxes -1.539 23.926 -6,04 23,39 -35.997 559.629
2017-05-12 2017-05-10 4 ASMB ASSEMBLY BIOSCIENCES, INC.
Common Stock
M - Exercise 5.000 25.465 24,43 7,20 36.000 183.348
2017-05-03 2017-05-01 4 DERM Dermira, Inc.
Director Stock Option (right to buy)
M - Exercise -500 18.275 -2,66
2017-05-03 2017-05-01 4 DERM Dermira, Inc.
Common Stock
S - Sale X -500 0 -100,00 34,06 -17.030
2017-05-03 2017-05-01 4 DERM Dermira, Inc.
Common Stock
M - Exercise 500 500 16,00 8.000 8.000
2017-04-04 2017-04-03 4 DERM Dermira, Inc.
Director Stock Option (right to buy)
M - Exercise -500 18.775 -2,59
2017-04-04 2017-04-03 4 DERM Dermira, Inc.
Common Stock
S - Sale X -500 0 -100,00 34,03 -17.015
2017-04-04 2017-04-03 4 DERM Dermira, Inc.
Common Stock
M - Exercise 500 500 16,00 8.000 8.000
2017-03-02 2017-03-01 4 DERM Dermira, Inc.
Director Stock Option (right to buy)
M - Exercise -500 19.275 -2,53
2017-03-02 2017-03-01 4 DERM Dermira, Inc.
Common Stock
S - Sale X -500 0 -100,00 35,09 -17.547
2017-03-02 2017-03-01 4 DERM Dermira, Inc.
Common Stock
M - Exercise 500 500 16,00 8.000 8.000
2017-03-01 2017-03-01 4 FPRX FIVE PRIME THERAPEUTICS INC
Stock Option (right to buy)
M - Exercise -500 21.000 -2,33
2017-03-01 2017-03-01 4 FPRX FIVE PRIME THERAPEUTICS INC
Common Stock
S - Sale X -500 0 -100,00 46,73 -23.365
2017-03-01 2017-03-01 4 FPRX FIVE PRIME THERAPEUTICS INC
Common Stock
M - Exercise 500 500 11,65 5.825 5.825
2017-02-16 2017-02-15 4 DERM Dermira, Inc.
Director Stock Option (right to buy)
M - Exercise -500 19.775 -2,47
2017-02-16 2017-02-15 4 DERM Dermira, Inc.
Common Stock
S - Sale X -500 0 -100,00 32,00 -16.000
2017-02-16 2017-02-15 4 DERM Dermira, Inc.
Common Stock
M - Exercise 500 500 16,00 8.000 8.000
2017-02-01 2017-02-01 4 FPRX FIVE PRIME THERAPEUTICS INC
Stock Option (right to buy)
M - Exercise -500 21.500 -2,27
2017-02-01 2017-02-01 4 FPRX FIVE PRIME THERAPEUTICS INC
Common Stock
S - Sale X -500 0 -100,00 46,17 -23.085
2017-02-01 2017-02-01 4 FPRX FIVE PRIME THERAPEUTICS INC
Common Stock
M - Exercise 500 500 11,65 5.825 5.825
2017-01-06 2017-01-04 4 IMDZ Immune Design Corp.
Stock Option (right to buy)
A - Award 10.000 10.000
2017-01-04 2017-01-04 4 DERM Dermira, Inc.
Director Stock Option (right to buy)
M - Exercise -500 20.275 -2,41
2017-01-04 2017-01-04 4 DERM Dermira, Inc.
Common Stock
S - Sale X -500 0 -100,00 32,00 -16.000
2017-01-04 2017-01-04 4 DERM Dermira, Inc.
Common Stock
M - Exercise 500 500 16,00 8.000 8.000
2017-01-03 2017-01-03 4 FPRX FIVE PRIME THERAPEUTICS INC
Stock Option (right to buy)
M - Exercise -500 22.000 -2,22
2017-01-03 2017-01-03 4 FPRX FIVE PRIME THERAPEUTICS INC
Common Stock
S - Sale X -500 0 -100,00 51,07 -25.535
2017-01-03 2017-01-03 4 FPRX FIVE PRIME THERAPEUTICS INC
Common Stock
M - Exercise 500 500 11,65 5.825 5.825
2016-12-16 2016-12-16 4 DERM Dermira, Inc.
Director Stock Option (right to buy)
M - Exercise -125 20.775 -0,60
2016-12-16 2016-12-16 4 DERM Dermira, Inc.
Common Stock
S - Sale X -125 0 -100,00 32,00 -4.000
2016-12-16 2016-12-16 4 DERM Dermira, Inc.
Common Stock
M - Exercise 125 125 16,00 2.000 2.000
2016-12-02 2016-12-01 4 DERM Dermira, Inc.
Director Stock Option (right to buy)
M - Exercise -375 20.900 -1,76
2016-12-02 2016-12-01 4 DERM Dermira, Inc.
Common Stock
S - Sale X -375 0 -100,00 32,00 -12.000
2016-12-02 2016-12-01 4 DERM Dermira, Inc.
Common Stock
M - Exercise 375 375 16,00 6.000 6.000
2016-12-02 2016-12-01 4 FPRX FIVE PRIME THERAPEUTICS INC
Stock Option (right to buy)
M - Exercise -500 22.500 -2,17
2016-12-02 2016-12-01 4 FPRX FIVE PRIME THERAPEUTICS INC
Common Stock
S - Sale X -500 0 -100,00 57,72 -28.860
2016-12-02 2016-12-01 4 FPRX FIVE PRIME THERAPEUTICS INC
Common Stock
M - Exercise 500 500 11,65 5.825 5.825
2016-11-10 2016-11-09 4 DERM Dermira, Inc.
Director Stock Option (right to buy)
M - Exercise -500 21.275 -2,30
2016-11-10 2016-11-09 4 DERM Dermira, Inc.
Common Stock
S - Sale X -500 0 -100,00 32,30 -16.150
2016-11-10 2016-11-09 4 DERM Dermira, Inc.
Common Stock
M - Exercise 500 500 16,00 8.000 8.000
2016-11-02 2016-11-01 4 FPRX FIVE PRIME THERAPEUTICS INC
Stock Option (right to buy)
M - Exercise -500 23.000 -2,13
2016-11-02 2016-11-01 4 FPRX FIVE PRIME THERAPEUTICS INC
Common Stock
S - Sale X -500 0 -100,00 48,67 -24.335
2016-11-02 2016-11-01 4 FPRX FIVE PRIME THERAPEUTICS INC
Common Stock
M - Exercise 500 500 11,65 5.825 5.825
2016-10-04 2016-10-03 4 DERM Dermira, Inc.
Director Stock Option (right to buy)
M - Exercise -500 21.775 -2,24
2016-10-04 2016-10-03 4 DERM Dermira, Inc.
Common Stock
S - Sale X -500 0 -100,00 34,25 -17.125
2016-10-04 2016-10-03 4 DERM Dermira, Inc.
Common Stock
M - Exercise 500 500 16,00 8.000 8.000
2016-10-04 2016-10-03 4 FPRX FIVE PRIME THERAPEUTICS INC
Stock Option (right to buy)
M - Exercise -500 23.500 -2,08
2016-10-04 2016-10-03 4 FPRX FIVE PRIME THERAPEUTICS INC
Common Stock
S - Sale X -500 0 -100,00 52,00 -26.000
2016-10-04 2016-10-03 4 FPRX FIVE PRIME THERAPEUTICS INC
Common Stock
M - Exercise 500 500 11,65 5.825 5.825
2016-09-02 2016-09-01 4 DERM Dermira, Inc.
Director Stock Option (right to buy)
M - Exercise -500 22.275 -2,20
2016-09-02 2016-09-01 4 DERM Dermira, Inc.
Common Stock
S - Sale X -500 0 -100,00 32,00 -16.000
2016-09-02 2016-09-01 4 DERM Dermira, Inc.
Common Stock
M - Exercise 500 500 16,00 8.000 8.000
2016-09-02 2016-09-01 4 FPRX FIVE PRIME THERAPEUTICS INC
Stock Option (right to buy)
S - Sale -500 24.000 -2,04
2016-09-02 2016-09-01 4 FPRX FIVE PRIME THERAPEUTICS INC
Common Stock
S - Sale X -500 0 -100,00 44,20 -22.100
2016-09-02 2016-09-01 4 FPRX FIVE PRIME THERAPEUTICS INC
Common Stock
M - Exercise 500 500 11,65 5.825 5.825
2016-08-03 2016-08-01 4 DERM Dermira, Inc.
Director Stock Option (right to buy)
M - Exercise -500 22.775 -2,15
2016-08-03 2016-08-01 4 DERM Dermira, Inc.
Common Stock
S - Sale X -500 0 -100,00 33,65 -16.825
2016-08-03 2016-08-01 4 DERM Dermira, Inc.
Common Stock
M - Exercise 500 500 16,00 8.000 8.000
2016-08-02 2016-08-01 4 FPRX FIVE PRIME THERAPEUTICS INC
Stock Option (right to buy)
S - Sale -500 0 -100,00
2016-08-02 2016-08-01 4 FPRX FIVE PRIME THERAPEUTICS INC
Common Stock
S - Sale X -500 0 -100,00 50,77 -25.385
2016-08-02 2016-08-01 4 FPRX FIVE PRIME THERAPEUTICS INC
Common Stock
M - Exercise 500 500 11,65 5.825 5.825
2016-06-23 2016-06-21 4 DERM Dermira, Inc.
Director Stock Option (right to buy)
A - Award 10.344 10.344
2016-06-15 2016-06-14 4 SGMO SANGAMO BIOSCIENCES INC
Stock Option (Right to Buy)
A - Award 10.000 10.000
2016-06-03 2016-06-02 4 ASMB ASSEMBLY BIOSCIENCES, INC.
Stock Option (Right to Buy)
A - Award 10.000 10.000
2016-05-23 2016-05-19 4 FPRX FIVE PRIME THERAPEUTICS INC
Stock Option (right to buy)
A - Award 10.000 0 -100,00
2016-05-19 2016-05-18 4 MRTX Mirati Therapeutics, Inc.
Option Grant (Right to Buy)
A - Award 10.000 10.000
2016-01-06 2016-01-04 4 IMDZ Immune Design Corp.
Stock Option (right to buy)
A - Award 9.300 9.300
2015-06-24 2015-06-22 4 SGMO SANGAMO BIOSCIENCES INC
Stock Option (Right to Buy)
M - Exercise 10.000 10.000
2015-06-16 2015-06-12 4 FPRX FIVE PRIME THERAPEUTICS INC
Stock Option (right to buy)
A - Award 12.500 12.500
2015-06-15 2015-06-11 4 DERM Dermira, Inc.
Director Stock Option (right to buy)
A - Award 8.620 8.620
2015-06-03 2015-06-03 4 SGMO SANGAMO BIOSCIENCES INC
Stock Option (Right to Buy)
M - Exercise -2.200 31.000 -6,63
2015-06-03 2015-06-03 4 SGMO SANGAMO BIOSCIENCES INC
Common Stock
S - Sale X -2.200 800 -73,33 12,44 -27.364 9.951
2015-06-03 2015-06-03 4 SGMO SANGAMO BIOSCIENCES INC
Common Stock
M - Exercise 2.200 3.000 275,00 6,05 13.310 18.150
2015-06-01 2015-05-28 4 ASMB ASSEMBLY BIOSCIENCES, INC.
Stock Option (Right to Buy)
A - Award 10.000 10.000
2015-05-22 2015-05-21 4 MRTX Mirati Therapeutics, Inc.
Option Grant (Right to Buy)
A - Award 15.000 15.000
2015-05-05 2015-05-04 4 SGMO SANGAMO BIOSCIENCES INC
Stock Option (Right to Buy)
M - Exercise 1.800 33.200 5,73
2015-05-05 2015-05-04 4 SGMO SANGAMO BIOSCIENCES INC
Stock Option (Right to Buy)
M - Exercise 1.200 0 -100,00
2015-05-05 2015-05-04 4 SGMO SANGAMO BIOSCIENCES INC
Common Stock
S - Sale X -3.000 800 -78,95 12,98 -38.927 10.381
2015-05-05 2015-05-04 4 SGMO SANGAMO BIOSCIENCES INC
Common Stock
M - Exercise 1.800 3.800 90,00 6,05 10.890 22.990
2015-05-05 2015-05-04 4 SGMO SANGAMO BIOSCIENCES INC
Common Stock
M - Exercise 1.200 2.000 150,00 6,41 7.692 12.820
2015-04-08 2015-04-06 4 SGMO SANGAMO BIOSCIENCES INC
Stock Option (Right to Buy)
M - Exercise -2.200 1.200 -64,71
2015-04-08 2015-04-06 4 SGMO SANGAMO BIOSCIENCES INC
Common Stock
S - Sale X -2.200 800 -73,33 14,95 -32.881 11.957
2015-04-08 2015-04-06 4 SGMO SANGAMO BIOSCIENCES INC
Common Stock
M - Exercise 2.200 3.000 275,00 6,41 14.102 19.230
2015-03-04 2015-03-03 4 SGMO SANGAMO BIOSCIENCES INC
Stock Option (Right to Buy)
M - Exercise -2.200 3.400 -39,29
2015-03-04 2015-03-03 4 SGMO SANGAMO BIOSCIENCES INC
Common Stock
S - Sale X -2.200 800 -73,33 17,21 -37.862 13.768
2015-03-04 2015-03-03 4 SGMO SANGAMO BIOSCIENCES INC
Common Stock
M - Exercise 2.200 3.000 275,00 6,41 14.102 19.230
2015-02-05 2015-02-03 4 SGMO SANGAMO BIOSCIENCES INC
Stock Option (Right to Buy)
M - Exercise -2.200 5.600 -28,21
2015-02-05 2015-02-03 4 SGMO SANGAMO BIOSCIENCES INC
Common Stock
S - Sale X -2.200 800 -73,33 12,70 -27.940 10.160
2015-02-05 2015-02-03 4 SGMO SANGAMO BIOSCIENCES INC
Common Stock
M - Exercise 2.200 3.000 275,00 6,41 14.102 19.230
2015-01-09 2015-01-07 4 IMDZ Immune Design Corp.
Stock Option (right to buy)
A - Award 9.300 9.300
2015-01-06 2015-01-05 4 SGMO SANGAMO BIOSCIENCES INC
Stock Option (Right to Buy)
M - Exercise -2.200 7.800 -22,00
2015-01-06 2015-01-05 4 SGMO SANGAMO BIOSCIENCES INC
Common Stock
S - Sale -2.200 800 -73,33 15,20 -33.430 12.156
2015-01-06 2015-01-05 4 SGMO SANGAMO BIOSCIENCES INC
Common Stock
M - Exercise 2.200 3.000 275,00 6,41 14.102 19.230
2014-10-07 2014-07-10 4/A ASMB ASSEMBLY BIOSCIENCES, INC.
Stock Option (right to buy)
A - Award 64.000 64.000
2014-10-02 2014-10-01 4 FPRX FIVE PRIME THERAPEUTICS INC
Stock Option (right to buy)
A - Award 25.000 25.000
2014-10-02 2014-10-02 4 DERM Dermira, Inc.
Director Stock Option (right to buy)
A - Award 23.275 23.275
2014-09-11 2014-09-09 4 MRTX Mirati Therapeutics, Inc.
Option Grant (Right to Buy)
A - Award 10.000 10.000
2014-07-14 2014-07-10 4 VTUS ASSEMBLY BIOSCIENCES, INC.
Stock Option (right to buy)
A - Award 64.000 64.000
2014-07-14 3 VTUS ASSEMBLY BIOSCIENCES, INC.
Common Stock
40.930
2014-07-14 3 VTUS ASSEMBLY BIOSCIENCES, INC.
Common Stock
40.930
2014-04-23 2014-04-21 4 SGMO SANGAMO BIOSCIENCES INC
Stock Option (Right to Buy)
A - Award 10.000 10.000
2014-03-21 2014-03-19 4 MRTX Mirati Therapeutics, Inc.
Option Grant (Right to Buy)
A - Award 15.000 15.000
2014-02-19 2014-02-14 4 SGMO SANGAMO BIOSCIENCES INC
Stock Option (Right to Buy)
M - Exercise -10.000 0 -100,00
2014-02-19 2014-02-14 4 SGMO SANGAMO BIOSCIENCES INC
Stock Option (Right to Buy)
M - Exercise -15.000 35.000 -30,00
2014-02-19 2014-02-14 4 SGMO SANGAMO BIOSCIENCES INC
Common Stock
S - Sale -25.000 800 -96,90 18,06 -451.575 14.450
2014-02-19 2014-02-14 4 SGMO SANGAMO BIOSCIENCES INC
Common Stock
M - Exercise 10.000 25.800 63,29 5,03 50.300 129.774
2014-02-19 2014-02-14 4 SGMO SANGAMO BIOSCIENCES INC
Common Stock
M - Exercise 15.000 15.800 1.875,00 6,05 90.750 95.590
2014-02-12 2013-01-30 5 SGMO SANGAMO BIOSCIENCES INC
Common Stock
G - Gift -5.000 800 -86,21
2013-10-03 2013-10-01 4 ONXX ONYX PHARMACEUTICALS INC
Stock Options
D - Sale to Issuer -5.900 0 -100,00
2013-10-03 2013-10-01 4 ONXX ONYX PHARMACEUTICALS INC
Stock Options
D - Sale to Issuer -2.000 0 -100,00
2013-10-03 2013-10-01 4 ONXX ONYX PHARMACEUTICALS INC
Stock Options
D - Sale to Issuer -5.000 0 -100,00
2013-10-03 2013-10-01 4 ONXX ONYX PHARMACEUTICALS INC
Stock Options
D - Sale to Issuer -5.417 0 -100,00
2013-10-03 2013-10-01 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -2.100 0 -100,00 125,00 -262.500
2013-10-03 2013-10-01 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
U - Other -7.737 2.100 -78,65 125,00 -967.125 262.500
2013-06-14 2013-06-12 4 SGMO SANGAMO BIOSCIENCES INC
Stock Option (Right to Buy)
A - Award 10.000 10.000
2013-04-01 2013-03-28 4 ONXX ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 5.900 5.900
2013-04-01 2013-03-28 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
A - Award 2.100 9.837 27,14
2013-01-22 2012-10-05 5 SGMO SANGAMO BIOSCIENCES INC
Common Stock
G - Gift -4.200 5.800 -42,00
2012-11-08 2012-11-07 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
S - Sale -1.300 7.737 -14,39 75,01 -97.514 580.359
2012-08-08 2012-08-06 4 ONXX ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy)
D - Sale to Issuer -7.500 12.500 -37,50
2012-08-08 2012-08-06 4 ONXX ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy)
D - Sale to Issuer -767 0 -100,00
2012-08-08 2012-08-06 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
S - Sale -4.190 9.037 -31,68 72,27 -302.811 653.104
2012-08-08 2012-08-06 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
M - Exercise 7.500 13.227 130,96 36,61 274.575 484.240
2012-08-08 2012-08-06 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
M - Exercise 767 5.727 15,46 35,18 26.983 201.476
2012-07-27 2012-07-25 4 ONXX ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 2.000 2.000
2012-07-27 2012-07-25 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
A - Award 1.500 4.960 43,35
2012-06-25 2012-06-21 4 SGMO SANGAMO BIOSCIENCES INC
Stock Option (Right to Buy)
A - Award 10.000 10.000
2012-04-03 2012-03-30 4 ONXX ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 5.000 5.000
2012-04-03 2012-03-30 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
A - Award 3.000 3.460 652,17
2008-04-03 3 PFE PFIZER INC
Common Stock
5.000
2004-05-25 2004-05-21 4 LJPC LA JOLLA PHARMACEUTICAL CO
Stock Options (right to buy)
A - Award 10.000 10.000
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)